| CLYM Market Cap History Table | ||||||||||||||||||
Below is a table of the CLYM market cap history going back to 8/12/2024:
Also see: CLYM Shares Outstanding History and CLYM YTD Return |
CLYM Market Cap History — Climb Bio Capitalization Over Time
As of 7/31/2026 Climb Bio has a market cap of 683.49 million. Investors often follow the CLYM market cap history to compare the size of the company over time.
This page shows CLYM market capitalization trends over time, with 8 market cap datapoints presented, dating back to 8/12/2024.
| CLYM Market Cap History Chart | ||||||||||||||||||||||||
CLYM Historical Market Cap: +31.02% CAGR 
Mouse over chart for data details
| ||||||||||||||||||||||||
| CLYM Stock Price Chart |
| About Climb Bio Inc |
| Climb Bio, Inc., formerly Eliem Therapeutics, Inc., is a clinical-stage biotechnology company. Co. is focused on developing therapeutics for patients with immune-mediated diseases. Co.'s lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody designed to deplete CD19-positive B cells, including antibody-secreting cells, in order to directly reduce pathogenic autoantibodies. The reduction of autoantibodies has the potential to be disease-modifying in autoantibody-driven diseases, such as systemic lupus erythematosus, immune thrombocytopenia, and membranous nephropathy. The budoprutug is in Phase I clinical trial. We show 8 historical shares outstanding datapoints in our CLYM shares outstanding history coverage, used to compute CLYM market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing CLYM market cap history over the course of time is important for investors interested in comparing CLYM's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of CLYM versus a peer is one thing; comparing CLYM market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like CLYM can fluctuate over the course of history. With this page we aim to empower investors researching CLYM by allowing them to research the CLYM market cap history. |
| CLYM Current Stock Quote |
Quotes delayed 20 minutes  Free CLYM Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| CLYM Share Performance |
| Market Cap Peers |
| Climb Bio (CLYM) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
CMAX Market Cap History CMD Market Cap History CMPI Market Cap History CMPX Market Cap History CMRA Market Cap History CMRX Market Cap History CNAT Market Cap History CNC Market Cap History CNCE Market Cap History CNMD Market Cap History More Healthcare companies » |
CLYM Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
